SABR plus surgery is effective for treating lung cancer February 22, 2019 -- Combining neoadjuvant stereotactic ablative radiotherapy (SABR) with surgery to treat patients with early-stage non-small cell lung cancer is more effective than SABR alone, according to a study published online February 21 in JAMA Oncology. Discuss
ViewRay secures FDA clearance for MRIdian upgrades February 21, 2019 -- Image-guided radiation therapy developer ViewRay has received clearance from the U.S. Food and Drug Administration (FDA) for new soft-tissue visualization capabilities for its MRIdian MRI-guided radiation therapy system.
Shorter radiotherapy works for prostate cancer treatment February 19, 2019 -- A shorter radiotherapy protocol for treating prostate cancer is comparable to a conventional radiotherapy schedule when it comes to disease-free survival and quality of life after treatment, according to a new study published online February 15 in JAMA Oncology. Discuss
Mirada gets FDA nod for dosimetry software February 18, 2019 -- Imaging software developer Mirada Medical has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Simplicit90Y dosimetry software.
Health Canada OKs AAA's Lutathera agent February 15, 2019 -- French molecular imaging firm Advanced Accelerator Applications (AAA) has received approval from Health Canada to market its Lutathera therapeutic agent for gastroenteropancreatic neuroendocrine tumors in adults with progressive disease.
Brachytherapy error halts treatment at Canadian center February 14, 2019 -- A cancer center in Hamilton, Ontario, has suspended brachytherapy treatment for cervical cancer patients after discovering that guide tubes of the wrong length were being used, meaning radiation may have missed the tumor target. The episode highlights the importance of anonymous error reporting, according to experts. Discuss
Advanced imaging offers insight into targeted therapies February 6, 2019 -- Major breakthroughs are emerging in the development of targeted therapies that use the body's own immune system to attack cancer cells. But traditional methods of measuring the success of drug candidates are slow and expensive. Could advanced imaging help? Diana Roettger, PhD, and Olga Kubassova, PhD, of the Image Analysis Group offer a perspective. Discuss
Elekta reports 1st treatment at Froedtert Hospital February 5, 2019 -- Radiation oncology firm Elekta said the Clinical Cancer Center at Froedtert Hospital in Milwaukee has treated its first patient with the company's Unity MR-guided radiation therapy system.
Radiation therapy (RT) could be more effective in African-American men with prostate cancer than previously realized, according to data presented at the American Society for Radiation Oncology (ASTRO) annual meeting. Read more